<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Bioequivalence Recommendations for CONCERTA (Methylphenidate Hydrochloride) Extended-Release Tablets; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Bioequivalence Recommendations for CONCERTA (Methylphenidate Hydrochloride) Extended-Release Tablets; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2014-11-06 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Bioequivalence Recommendations for CONCERTA (methylphenidate hydrochloride) Extended- Release Tablets." The recommendations provide specific guidance on the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) that reference the listed drug CONCERTA (methylphenidate hydrochloride (HCl)) extended-release tablets (new drug application (NDA) 021121)....</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2014-26306</p>
    <p><strong>Publication Date:</strong> 2014-11-06</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2014/11/06/2014-26306/bioequivalence-recommendations-for-concerta-methylphenidate-hydrochloride-extended-release-tablets">https://www.federalregister.gov/documents/2014/11/06/2014-26306/bioequivalence-recommendations-for-concerta-methylphenidate-hydrochloride-extended-release-tablets</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2014-26306</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
